Upload
laytailieu2015
View
228
Download
1
Embed Size (px)
Citation preview
7/21/2019 Phn Tch Hot ng Phn Ph i Thuc Ca Cng Ty C Phn Traphaco Giai on 2010 - 2012
1/65
BY T
TRNG I HC DC H NI
IU HUY QUN ANH
KHO ST C CU V XU HNG
NHP KHU THUC IU TRI THO NG TI VIT NAM
GIAI ON 2006-2011
KHA LUN TT NGHIP DC S
H NI 2013
7/21/2019 Phn Tch Hot ng Phn Ph i Thuc Ca Cng Ty C Phn Traphaco Giai on 2010 - 2012
2/65
BY T
TRNG I HC DC H NI
IU HUY QUN ANH
KHO ST C CU V XU HNGNHP KHU THUC IU TR
I THO NG TI VIT NAMGIAI ON 2006-2011
KHA LUN TT NGHIP DC S
Ngi hng dn:
1.DS. Nguyn Vnh Nam2. ThS. Chu Quc Thnh
Ni thc hin:
1.
Bmn Qun l v Kinh tdc
Trng i hc Dc H Ni
2.Phng Qun l gi thuc
Cc Qun l Dc - BY t
H NI 2013
7/21/2019 Phn Tch Hot ng Phn Ph i Thuc Ca Cng Ty C Phn Traphaco Giai on 2010 - 2012
3/65
LI CM N
Ti xin c by tlng bit n chn thnh v su sc nht n:
ThS. Chu Quc Thnh Chuyn vin Phng Qun l gi thuc Cc
Qun l Dc BY t, ngi cung cp cho ti cc sliu, hng dn v
gi cho ti vphng php nghin cu.
DS. Nguyn Vnh Nam Bmn Qun l v kinh tDc Trng
i hc Dc H Ni, thy lun tn tnh hng dn, ng vin v cho ti
nhiu kin thc qu bu hon thnh kha lun tt nghip ny.
ThS. Nguyn ThH Bmn Qun l v kinh tDc Trng i
hc Dc H Ni, c cho ti nh ng li khuyn qu bu v gip ti
trong sut thi gian lm kha lun.
Ti cng xin cm n cc thy c gio Trng i hc Dc H Ni,
c bit cc thy c Bmn Qun l v Kinh tDc tn tnh dy dti
trong sut thi gian hc tp ti trng.
Cui cng ti xin gi li cm n su sc n gia nh v bn b khch lng vin ti t c nhng thnh cng ngy hm nay.
H ni, ngy 21 thng 05 nm 2013.
Sinh vin
iu Huy Qun Anh
7/21/2019 Phn Tch Hot ng Phn Ph i Thuc Ca Cng Ty C Phn Traphaco Giai on 2010 - 2012
4/65
MC LC
DANH MC CC CHVIT TT
DANH MC CC BNG
DANH MC CC HNH
T VN .................................................................................................. 1
Chng 1. TNG QUAN............................................................................... 2
1.1. Tng quan vbnh i tho ng ...................................................... 2
1.1.1. nh ngha bnh i tho ng................................................... 2
1.1.2. Phn loi i tho ng............................................................... 2
1.1.3. Tnh hnh i tho ng ti Vit Nam v trn thgii................ 2
1.2. Tng quan vthuc v iu tri tho ng .................................... 3
1.2.1. Cc nhm thuc iu tri tho ng....................................... 3
1.2.2. iu tri tho ng.................................................................. 4
1.3. Tng quan vthtrng thuc nhp khu v thuc iu tritho ....
ng Vit Nam ............................................................................................. 8
1.3.1. Vai tr ca thuc nhp khu.......................................................... 8
1.3.2. Vtr thuc iu tri tho ng trong thtrng thuc nhp ...
khu Vit Nam............................................................................................. 9
1.4. Tng quan vnghin cu nh lng sdng thuc ......................... 10
1.4.1. Nghin cu chi ph....................................................................... 10
1.4.2. Nghin cu da trn slng n vng gi........................... 11
1.4.3. Nghin cu da trn n thuc.................................................... 11
1.4.4. Nghin cu da trn liu trung bnh sdng hng ngy............ 12
1.5. Cc nghin cu tng tti Vit Nam v trn thgii ..................... 12
1.5.1. Cc nghin cu vsdng/ tiu ththuc iu tri tho ng
trn thgii............................................................................................... 13
1.5.2. Cc nghin cu tng tti Vit Nam........................................ 13
7/21/2019 Phn Tch Hot ng Phn Ph i Thuc Ca Cng Ty C Phn Traphaco Giai on 2010 - 2012
5/65
Chng 2. I TNG V PHNG PHP NGHIN CU............. 15
2.1. i tng nghin cu ......................................................................... 15
2.2. Thi gian v a im nghin cu ...................................................... 15
2.3. Thit knghin cu ............................................................................ 15
2.4. Ni dung nghin cu .......................................................................... 15
2.5. Cc ch snghin cu ........................................................................ 15
2.6. Thu thp v lm sch dliu .............................................................. 16
2.7. Xl sliu........................................................................................ 18
2.8. Trnh by v bo co kt qu.............................................................. 18
Chng 3. KT QUNGHIN CU........................................................ 19
3.1. Gi trkim ngch nhp khu v slng sng k cc thuc iu tr
i tho ng nhp khu vo Vit Nam (2006-2011) ............................... 19
3.1.1. Gi trkim ngch nhp khu cc thuc iu tri tho ng .....
nhp khu (2006-2011)............................................................................. 19
3.1.2. Slng sng k cc thuc iu tri tho ng nhp khu(2006-2011)............................................................................................... 19
3.2. C cu v xu hng nhp khu cc nhm thuc iu tri tho.........
ng (2006-2011) ...................................................................................... 20
3.2.1. Kho st da trn gi trkim ngch nhp khu.......................... 20
3.2.2. Kho st da trn slng sng k........................................ 21
3.2.3. Kho st da trn tng sliu DDD........................................... 223.3. C cu v xu hng nhp khu cc hot cht iu tri tho ng ..
(2006 2011) ............................................................................................... 24
3.3.1. Kho st da trn gi trkim ngch nhp khu.......................... 24
3.3.2. Kho st theo slng sng k.............................................. 26
3.3.3. Kho st theo tng sliu DDD.................................................. 28
7/21/2019 Phn Tch Hot ng Phn Ph i Thuc Ca Cng Ty C Phn Traphaco Giai on 2010 - 2012
6/65
3.4. C cu v xu hng nhp khu cc thuc iu tri tho ng theo
quc gia xut x(2006-2011) ...................................................................... 29
3.4.1. Kho st theo kim ngch nhp khu. ........................................... 30
3.4.2. Kho st theo slng sng k.............................................. 32
Chng 4. BN LUN................................................................................. 34
4.1. Bn lun vkt qunghin cu ......................................................... 34
4.1.1. Xu hng chung vnhp khu cc thuc iu tri tho ng ..
...................................................................................................... 34
4.1.2. Xu hng nhp khu cc nhm thuc iu tri tho ng ... 34
4.1.3. Xu hng nhp khu cc hot cht iu tri tho ng....... 35
4.2. Hn chca ti ............................................................................... 38
4.2.1. Hn chvphng php nghin cu........................................... 38
4.2.2. Hn chvdliu nghin cu..................................................... 38
4.2.3. Hn chvbin gii kt qu........................................................ 39
KT LUN V KIN NGH...................................................................... 40
TI LIU THAM KHO
PHLC
7/21/2019 Phn Tch Hot ng Phn Ph i Thuc Ca Cng Ty C Phn Traphaco Giai on 2010 - 2012
7/65
DANH MC CC K HIU, CH VIT TT
ADA : Hip hi i tho ng hoa k
DDD : Liu trung bnh sdng hng ngy
T : i tho ng
EASD : Hip hi nghin cu i tho ng Chu u
Ins : Insulin
IDF : Lin on i tho ng quc t
KNNK : Kim ngch nhp khu
Met : Metformin
NK : Nhp khu
Pio : Pioglitazon
TLS : Thay i li sng
TZD : Thiazolidinedion
SK : Sng k
Sul : Sulfonamid v dn xut ure
WHO : Tchc y tThGii
7/21/2019 Phn Tch Hot ng Phn Ph i Thuc Ca Cng Ty C Phn Traphaco Giai on 2010 - 2012
8/65
DANH MC CC BNG
Bng 1.1. Ttrng thuc trong nc v nhp khu ......................................... 9
Bng 1.2. Gi trv ttrng gi trmt snhm thuc nhp khu ti Vit .......
Nam ................................................................................................ 10
Bng 2.1. Danh mc cc hot cht iu tri tho ng trong nghin cu 17
Bng 3.1. Gi trkim ngch nhp khu v ttrng gi trkim ngch nhp .......
khu thuc iu tri tho ng (2006-2011) ........................... 19
Bng 3.2. Slng sng kcc thuc iu tri tho ng nhp khu ....
(2006-2011).................................................................................... 19
Bng 3.3. Gi trkim ngch nhp khu ca mt sbit dc iu tri tho..
ng c xut xtPhp. ............................................................. 32
7/21/2019 Phn Tch Hot ng Phn Ph i Thuc Ca Cng Ty C Phn Traphaco Giai on 2010 - 2012
9/65
DANH MC CC HNH
Hnh 1.1. Phc iu trT ca Hip hi i tho ng Mv hip hi ..
nghin cu i tho ng Chu u nm 2009 .............................. 8
Hnh 3.1 Gi trv ttrng kim ngch nhp khu cc nhm thuc iu tri.
tho ng...................................................................................... 21
Hnh 3.2 Slng sng kca cc nhm thuc iu tri tho ng ......
(2006-2011).................................................................................... 22
Hnh 3.3. Tng sliu v ttrng tng sliu DDD ca cc nhm thuc ......
iu tri tho ng (2006 2011) ........................................... 23
Hnh 3.4. Gi trkim ngch nhp khu ca cc hot cht iu tri tho........
ng v ttrng (2006-2011) ...................................................... 26
Hnh 3.5. Slng sng kca cc hot cht iu tri tho ng nhp .
khu ................................................................................................ 27
Hnh 3.6. Tng sliu DDD v ttrng tng sliu DDD ca cc hot cht...iu tri tho ng ................................................................... 28
Hnh 3.7. Gi trv ttrng gi trkim ngch nhp khu theo xut xca cc
thuc iu tri tho ng ......................................................... 31
Hnh 3.8. Slng sng ktcc quc gia c thuc iu tri tho.........
ng Vit Nam giai on 2006-2011 ....................................... 33
7/21/2019 Phn Tch Hot ng Phn Ph i Thuc Ca Cng Ty C Phn Traphaco Giai on 2010 - 2012
10/65
1
T VN
Cng vi spht trin vkinh t, cht lng cuc sng c nng cao
khin cho cc bnh mn tnh ni chung v bnh i tho ng ni ring ngy
cng trnn phbin. Theo c tnh ca Tchc y tthgii, vi tc gia
tng slng bnh nhn hin nay, khong 4,4% dn sthgii smc bnh
i tho ng vo nm 2030[23]. Mc d l mt quc gia ang pht trin,
cc thng k dch thc cho thy ti Vit Nam vo nm 2010, c kho ng
3% dn smc bnh ny [24].
Tc pht trin bnh nhanh nh vy l mt thch thc ln vi ngnh
Y tcng nh ngnh Dc Vit Nam.thc hin tt mc tiu cung ng y
c v s lng v cht lng cc thuc iu tr i tho ng, ngnh
Dc khng nhng phi pht trin v quy m v danh mc thuc sn xut
trong nc m cn phi nhp khu thuc.
Mc d vai tr thuc nhp khu trong iu tr i tho ng l rt
quan trng, tuy nhin hin nay, cha c mt kho st no nh gi c cu vxu hng nhp khu thuc iu tri tho ng. Trn c s, chng ti
thc hin ti Kho st c cu v xu hng nhp khu thuc iu tr
i tho ng giai on 2006-2011 vi hai mc tiu:
1. Kho st c cu nhp khu thuc iu tri tho ng vo Vit
Nam giai on 2006-2011.
2. Kho st xu hng nhp khu thuc iu trvo Vit Nam giai on2006-2011.
7/21/2019 Phn Tch Hot ng Phn Ph i Thuc Ca Cng Ty C Phn Traphaco Giai on 2010 - 2012
11/65
2
Chng 1. TNG QUAN
1.1. Tng quan vbnh i tho ng
1.1.1.
nh ngha bnh i tho ng
Theo Tchc y tthgii (WHO): i tho ng (T)l mt bnh
mn tnh gy ra bi sthiu ht tngi hay tuyt i insulin, dn n cc
ri lon chuyn ha hydratcacbon. Bnh c c trngbi tnh trng tng
ng huyt mn tnh v cc ri lon chuyn ha [4].
1.1.2.Phn loi i tho ng
i tho ng typ1: Do bnh tmin dch, cc tbo beta tuyn ty
bph hy bi cht trung gian min dch,s ph hy ny c thnhanh hay
chm. Tin trin nhanh hay gp ngi tr
7/21/2019 Phn Tch Hot ng Phn Ph i Thuc Ca Cng Ty C Phn Traphaco Giai on 2010 - 2012
12/65
3
Theo Lin on Tquc t(International Diabetes Federation IDF)
cng trong nm 2012 c ti 4,8 triu ngi cht v bnh i tho ng,
mt na trong s tui di 60 tui. Thgii chi hn 471 tUSD
cho bnh Tnm 2012[15].
Nm 2002, theo iu tra trn phm vi ton quc la tui 30-64 ca
Bnh vin Ni tit Trung ng, t lmc bnh T chung ca cnc l
2,7%, cc thnh phl 4,4%, vng ng bng ven bin 2,2% v min ni l
2,1% [1]. Ti 2010 theo t chc y t thgii Vit Nam c khong 2,64
triu ngi tng ng 3% dn smc bnh [24].
1.2. Tng quan vthuc v iu tri tho ng
1.2.1.Cc nhm thuc iu tri tho ng
1.2.1.1. Insulin
o Chnh:
L bt buc vi T typ1 v T thai k [2].
S dng cho T typ 2 khi c: nhim trng, vt thng cp, tngng huyt vi tng ceton mu cp nng, c thai, suy gan,suy thn, dng
hay tht bi vi cc thuc ung hng huyt, khi c chnh tm thi ngay
khi ng huyt tng >250-300 mg/dl hay HbA1c>11%, v mt s trng
hp khc [2].
o Phn loi insulin theo thi gian tc dng [2],[4],[12].
- Loi tc dng nhanh nh Lispro, Aspart,Glulisin.- Loi tng i nhanh nh Regular.
- Loi tc dng trung gian nh Lente hay NPH.
- Loi tc dng ko di nh Glargin, Ultralente, Detemir .
- Loi hn hp nh 70%NPH /30%Regular hay 75%NPH /25%Lispro.
Trong :meal-insulin l loi tc dng nhanh v tng i nhanh [12].
7/21/2019 Phn Tch Hot ng Phn Ph i Thuc Ca Cng Ty C Phn Traphaco Giai on 2010 - 2012
13/65
4
1.2.1.2. Cc thuc iu tri tho ng ng ung
- Nhm thuc kch thch ty bi tit insulin (sulfonamide/xut ure):
glyclazid, glimepirid, glibenclamid, gliburid, glipizid [2].
- Nhm thuc lm tng nhy cm insulin ngoi vi, gim khng
insulin: biguanid, thiazolidinedion [2].
Biaguanid: metformin.
Thiazolidinedione: pioglitazon, rosiglitazon.
- Nhm c ch emzyme alpha glucosidase lm gim hp thu glucose:
acarbose, voglibose, miglitol [2].
- Nhm glinid: kch thch tbo beta tuyn ty tit insulin. Gm cc hot
cht nh: meglitinid, repaglinid.
- Nhm cc thuc tc dng trn hincretin:
Cc thuc ng phn GLP-1 (glucagon-like peptide 1): lm gim
ng huyt sau n. V d: exenatid.
Thuc c ch emzym phn hy GLP-1 l DPP IV (dipeptidylpeptidase IV): lm tng nng v tc dng ca GLP-1 ni sinh.
ng phn amylin: tc dng theo c chlm chm trng ddy,
c chtit glucagon, tng GLP[4].
1.2.2.iu tri tho ng
1.2.2.1. iu trkhng dng thuc
- Chn: vi T typ 1 n calo, vi T typ 2 n t calo (t hn1200Kcal/ngy ), n nhiu ba nhv gin phi u. Khu phn n
cn i (50-60% glucid, 30-35% lipid, 10% protid), m bo vitamin,
khong cht, hn chcc loi ng hp thu nhanh, king ru [4],[2].
- Vn ng thlc l rt quan trng v cn thit, c bit l T typ 2.
Luyn tp ty theo la tui v tnh trng tim mch ca bnh nhn [4].
7/21/2019 Phn Tch Hot ng Phn Ph i Thuc Ca Cng Ty C Phn Traphaco Giai on 2010 - 2012
14/65
5
- Kim sot ng huyt bng cch nh lng ng huyt thng
xuyn chnh liu thuc cho ph hp [4].
- Gio dc bnh nhn nhng kin thc vT bnh nhn phi hp
tt trong iu tr, bit cch t dng thuc v phng nga c bin
chng [4].
- Khm nh k theo di cc bin chng v c tham vn ca bc s
khi c vn c bit xy ra [4].
1.2.2.2. Cc phc iu tr
a. Cc phc iu trbng insulin
C nhiu phc iu trinsulin khc nhau. i vi T typ 1 thng
sdng cc phc 2- 4 mi/ ngy. i vi T typ 2 ngoi phc nh
T typ 1 c thsdng thm phc 1 mi insulin kt hp vi thuc vin
(insulatard, lantus) [2].
T thai kthng sdng phc 1-4 mi/ ngy ty theo nng
ng huyt bnh nhn. Chsdng loi insulin tng hp (actrapid, mixtard,insulatard) [2].
- Phc 1 mi insulin : phi hp thuc vin iu tr T vi 1 mi
insulin tc dng trung gian hoc hn hp vo trc ba n ti hoc 1
mi insulin tc dng trung gian hoc Glargin (lantus) vo bui ti trc
khi i ng.
- Phc 2 mi insulin: thng s dng 2 mi insulin tc d ng trunggian hoc insulin hn hp tim trc n sng v ti. Chia liu 2/3 trc
ba im tm sng, 1/3 trc ba n ti. Khi vi phc trn tht bi,
chn v chsinh hot tht thng hoc khi cn kim sot cht
chng huyt nh khi c thai hoc khi c cc bin chng nng cn
sdng cc phc khc vi nhiu mi insulin[2].
7/21/2019 Phn Tch Hot ng Phn Ph i Thuc Ca Cng Ty C Phn Traphaco Giai on 2010 - 2012
15/65
6
- Phc nhiu mi insulin: tim 3 ln trong ngy: 2 mi nhanh v 1 mi
bn chm hoc 2 mi bn ch m hoc insulin nn. Tim 4 ln trong
ngy: 3 mi insulin tc dng nhanh trc 3 ba n v 1 mi insulin nn
loi NPH trc khi nghoc Glargin (lantus) [2].
b. Phc iu trTtyp 2 ca IDF nm2005 v 2012
Trong c 2 phc ny, metformin l u tin s dng u tin cho
kim sot ng huyt, tip n l sulfonamid/dn xut ure. iu ny cho
thy trong giai on nghin cu, khng c s thay i v vai tr ca
metfomin v sulfonamid trong vic kim sot ng huyt.- Phc iu trT ca IDF nm2005 [16]
Bc 1. Thay i li sng.
Bc 2. Sdng metformin, theo di chc nng thn khi sdng.
Bc 3. Sdng sulfonamid/dn xut ure khi metformin khng kim
sot c ng huyt. Insulin tc dng nhanh c ththay thsulfonamid.
Bc 4. Sdng (thiazolidindion + metformin) hoc (thiazolidinedion+ sulfonamid) hoc (thiazolidinedion + mt thuc dng kt hp ca
metformin v sufonamid) khi bc 3 khng t c mc tiu iu tr.
Bc 5. S dng cht c ch alpha glucosidase nh mt thuc thm
vo.
Bc 6. Tng liu, dng thm cc thuc h ng huyt khc, dng
insulin.- Phc iu trT typ 2 ca IDF nm 2012 [14]
Bt u vic iu trbng cch thay i li sng, nu khng t mc
tiu mi bc (thng l HbA1C
7/21/2019 Phn Tch Hot ng Phn Ph i Thuc Ca Cng Ty C Phn Traphaco Giai on 2010 - 2012
16/65
7
Bc 2. S dng sulfonamid/dn xut ure, c th thay th bng mt
trong cc thuc: metformin, cht c chalphaglucosidase, thiazolidinedion,
DPP-4.
Bc 3. La chn mt trong cc thuc: insulin tc dng ko di, insulin
dng hn hp, c chalpha-glucosidase, DPP-4, thiazolidinedion, c ththay
thbng cht ng vn GLP1.
Bc 4. La chn mt trong cc thuc: mt insulin tc dng ko di v
mt meal-time insulin, insulin nn hoc insulin hn hp.
c. Phc iu trT ca hip hi T Mv hip hi nghin cu T
Chu u
Chin lc iu trT typ 2 theo ng thun ca Hip hi T M
(American Dental Asociation -ADA) v Hip hi nghin cu T chu u
(European Association for the Study of Diabetes - EASD) a ra nm 2009
c trnh by trong hnh 1.1.
Thnh 1.1 pha di ta thy:Trong phc loi 1, l phc c u tin iu trth metformin,
sulfonamid/dn xut ure v insulin l nhng nhm thuc quan trng nht
trong vic kim sot ng huyt.
Phc 1 l cc phc iu trhiu quv kinh tnht. Cc phc
ny c a ra da vo cc kt quthnghim lm sng, v c chng
minh l gip t c HbA1c ch nn c la chn cho hu ht cc bnhnhn.
Phc loi 2 khc vi loi 1 bc thhai v thba. Phc loi 2
ny thng c p dng t phbin hn phc loi 1.
7/21/2019 Phn Tch Hot ng Phn Ph i Thuc Ca Cng Ty C Phn Traphaco Giai on 2010 - 2012
17/65
8
Hnh 1.1. Phc iu trT ca ADA v EASD nm 2009[17]
1.3.
Tng quan v th trng thuc nhp khu v thuc iu tr itho ng ti Vit Nam
1.3.1.Vai tr ca thuc nhp khu
Trong thi gian gn y, nhu cu sdng thuc ca ngi dn ngy
cng tng cao. Tin thuc bnh qun u ngi 2008 (16,45 USD/ ngi) tng
gp hn 2 ln so vi nm 2004 (8,6 USD/ngi) [5]. Trc nhu cu sdng
thuc ca ngi dn ngy cng tng vcslng v cht lng th ngnh
Chn on T: Thayi li sng (TLS) +
Met
TLS+Met+Sul
TLS+ Met+Insulin nn
TLS +Met+ Ins tch
cc
TLS + Met+ PioKhng gy hGluose mu
Gy ph,suy tim, Mtxng
TLS +Met+ ng vnGLP-1
Khng hglucose muGim cn, nn, bun nn
TLS+ Met+
Pio+Sul
TLS +
Met+Ins nn
BC 1 BC 2 BC 3
LOI 2: t c bng chng hn
Ghi ch:
TLS: Thay i lisng,
Met: metformin,
Sul: Sulfonamid/dnxut ure,
Pio: Pioglitazone,Ins: Insulin.
LOI 1: iu trc bn, y bng chng
7/21/2019 Phn Tch Hot ng Phn Ph i Thuc Ca Cng Ty C Phn Traphaco Giai on 2010 - 2012
18/65
9
dc cn khng ngng pht trin vquy m v cht lng. Bn cnh , kh
nng sn xut thuc trong nc cn hn ch(thuc thnh phm chp ng
c 50% nhu cu sdng thuc ca nhn dn, 90% nguyn liu lm thuc
vn phi nhp khu). Do , thuc nhp khu ng vai tr r t quan trng
trong hthng y tnc ta.
So snh ttrng thuc trong nc v thuc nhp khu da trn tng gi
trtin thuc tnm 2006-2010 c thhin bng 1.2. Theo ta thy, t
trng thuc nhp khu l tng ng vi thuc trong nc.
Bng 1.1. Ttrng thuc trong nc v nhp khu [9]
Nm Tng gi trtinthuc
(Triu USD)
Thuc trong nc Thuc nhp khu
Gi tr(Triu USD)
Ttrng%
Gi tr(Triu USD)
Ttrng%
2006 956,353 475,400 49,71 548,200 50,29
2007 1136,350 600,630 52,86 597,082 47,14
2008 1425,660 715,440 50,18 759,752 49,82
2009 1686,140 831,210 49,01 859,763 50,992010 1913,660 919,040 48,03 994,529 51,97
1.3.2.Vtr thuc iu tri tho ng trong thtrng thuc nhp khu
Vit Nam
Ti Vit Nam, thuc iu tr cc bnh nhim khun c t trng kim
ngch nhp khu (KNNK) ln nht (>21% mi nm). ng th2 l cc thuc
iu trcc bnh vng tiu ha v chuyn ha (> 18% mi nm) [5].Thuc iu tr bnh T nm trong nhm cc thuc iu tr bnh
ng tiu ha v chuyn ha (nhm A) v lun c ttrng KNNK ln th3
trong nhm A, ln lt l 16,1%, 13,3%, 17,0% trong 3 nm t2006-2008 so
vi tng KNNK ca nhm A [5].
Gi trv ttrng 1 snhm thuc c KNNK ln vo Vit Nam c
thhin bng 1.2 [5].
7/21/2019 Phn Tch Hot ng Phn Ph i Thuc Ca Cng Ty C Phn Traphaco Giai on 2010 - 2012
19/65
10
Bng 1.2. Gi trv ttrng gi trmt snhm thuc nhp khu ti
Vit Nam [5]
Nhm thuc theom bc 1 phn loi
ATC
Nm 2006 Nm 2007 Nm 2008Gi tr(TriuUSD)
Ttrng
%
Gi tr(TriuUSD)
Ttrng
%
Gi tr(TriuUSD)
Ttrng
%A - ng tiu ha
v chuyn ha.93,5 18,2 138,0 20,0 148,7 18,1
J - Hkhng khun 129,1 25,1 148,7 21,4 206,3 24,8
C - Htim mch 48,5 9,4 60,9 8,8 77,7 9,4
Tng cc nhmthuc 513,7 100,0 690,5 100,0 829,5 100,0
1.4. Tng quan vnghin cu nh lng sdng thuc
Ni dung chnh ca ti l kho st c cu v xu hng nhp khu
thuc iu trT. Trong qu trnh phn tch kt qu, cc chsnghin cu
khc nhau bao gm kim ngch nhp khu (thhin gi trbng tin), tng s
liu trung bnh sdng hng ngy (Defined Daily Dose DDD) (thhin gi
trsdng), tng sng k (thhin mc cnh tranh) sc a vo
phn tch song song vi tng ni dung nghin cu. Cc chsny c rt ra
da trn cc nghin cu nh lng vsdng, tiu ththuc. Do , chng
ti thc hin phn tng quan ny nhm m tcc loi nghin cu v cc ch
stng ng cc nghin cu vsdng/tiu ththuc.
1.4.1.Nghin cu chi ph
Cc nghin cu v chi ph thuc em li thng k ban u v tng
quan gia chi ph sdng thuc so vi tng chi ph y t, c bit trn quy m
quc gia. Trn thc t, khi trin khai cc nghin cu ny, nh nghin cu
thng thc hin so snh gia chi ph sdng thuc vi thu nhp bnh qun
u ngi [13].
Nghin cu vchi ph c mt shn chnh: khng cung cp chnh
xc vslng thuc c bn ra hay slng thuc thc tc ngi dn
7/21/2019 Phn Tch Hot ng Phn Ph i Thuc Ca Cng Ty C Phn Traphaco Giai on 2010 - 2012
20/65
11
s dng, hn na gi thuc khc nhau gia cc quc gia gy ra nhng kh
khn trong vic so snh chi ph tiu ththuc gia cc quc gia. Nghin cu
di hn cng gp kh khn do nhng bin ng vtin tv nhng thay i
trong gi thuc [11],[20].
1.4.2.Nghin cu da trn slng n vng gi
nh gi s tiu th da trn s lng n v ng gi (vin, l,
ng,...) a ra nhng nh gi chnh xc v tiu th thuc hn l nh gi
theo chi ph. Nghin cu ny hay c sdng nh gi s dng thuc
trong cmt giai on hoc so snh gia cc quc gia [11].
Hn ch ca nghin cu ny l ng vi cng mt hot cht theo thi
gian v gia cc quc gia c thc nhiu bit dc vi dng bo ch, nng
, hm lng v quy cch ng gi khc nhau, do gy kh khn cho vic
nh lng tiu th. Tuy nhin, nu lm c cc nghin cu ny scho thy
bin ng vchng loi bit dc ng vi dng mt hot cht, theo thi gian
[11].1.4.3.Nghin cu da trn n thuc
Nghin cu ny c thphn nh mi quan hgia ngi thy thuc v
bnh nhn v sthay i ca mi quan h trong mt giai on thi gian.
Hn chca phng php ny l khng ththc hin c trkhi skho st
bao gm cnhng chn on v nhng vn lin quan khc. Khng may l,
nhng thng tin ny thng rt kh c c v mt vi l do hn n a skho st loi ny c trngi l thng t [11].
7/21/2019 Phn Tch Hot ng Phn Ph i Thuc Ca Cng Ty C Phn Traphaco Giai on 2010 - 2012
21/65
12
1.4.4.Nghin cu da trn liu trung bnh sdng hng ngy
Liu DDD: l liu tng cng trung bnh ca mt thuc dng cho mt
ngy cho mt chnh ngi trng thnh [3].
ngha:DDD l mt n vo lng kthut vsdng thuc, c
ngha theo di, gim st, nh gi vtnh hnh tiu thv sdng hp l
hay khng [3].
DDD c sdng trong cc nghin cu tiu ththuc thng qua tnh
ton v tng s liu DDD. Cc nghin cu ny scho thy thc tv tng
lng thuc tiu thca qun thnghin cu.
Cc nghin cu ny ph hp gim st, nh gi vtnh hnh tiu th
v sdng ca cc thuc iu trbnh mn tnh c liu quy nh gn vi liu
DDD. V dnh: cc thuc iu trT, c bit l cc thuc iu trT
ng ung [11],[20].
Hn chca phng php nghin cu ny:
- Th nht l, nghin cu tiu th thuc s dng cc d liu trn ccthuc c k n hoc bn ra cho bnh nhn. Tuy nhin, khng phi
tt ccc thuc ny u c bnh nhn sdng ht [11].
- Mt sthuc khng thdung liu DDD theo di, nh gi tnh hnh
sdng thuc: dch truyn, vac xin,thuc t, m, thuc ngoi da, cn
quang [3].
1.5.
Cc nghin cu tng tti Vit Nam v trn thgiiTnh ti thi im nghin cu, chng ti cha tm c nghin cu no
trn thgii kho st thc trng nhp khu thuc iu trT cng nh phn
tch vai tr ca thuc iu trT nhp khu. Tuy nhin, c mt snghin
cu vtiu thv sdng thuc iu trT c thc hin. Cthl:
7/21/2019 Phn Tch Hot ng Phn Ph i Thuc Ca Cng Ty C Phn Traphaco Giai on 2010 - 2012
22/65
13
1.5.1.Cc nghin cu v s dng/tiu th thuc iu tri tho ng
trn thgii
Nghin cu v xu hng k n cho bnh nhn i tho ng ca
Marta Baviera v cng s trn hn 9 triu dn Lombardy-Italia thc hin
nm 2008. Nghin cu ly s liu t c s d liu qun l sc khe ca
Lombardy giai on 2000-2008. Kt qunghin cu cho thy:
Trong giai on nghin cu.
- T lbnh nhn c iu trbng biguanid v sulfonamide/dn cht
ure l cao nht (> 50%).
- Tlbnh nhn c iu trbng biguanid tng t53,4% - 66,5%.
- Tlbnh nhn c iu trbng sulfonamid/dn xut ure gim dn
t78,6% xung cn 56,4%
- Tlbnh nhn sdng insulin t c sthay i.
- C sra tng sdng thiazolidinedion t0,8 - 5,7% [10].
Nghin cuvsdng thuc iu trT ti Hungary ca B.Hankov cng strn dliu ths bo him y tquc gia v cng ty t vn MIS
giai on 1998-2002. Kt qunghin cu cho thy:
- Sulfonamid/dn xut ure c dng nhiu nht trong nhng thuc iu
trT ng ung v cao gp gn hai ln so vi biguanid l thuc
iu trT ng ung c dng nhiu thhai [13].
1.5.2.
Cc nghin cu tng tti Vit Nama. Cc nghin cu vsdng thuc iu tri tho ng ti Vit Nam
Nghin cu ca o Mai Hngvsdng thuc iu trT ng
ung ti khoa khm bnh bnh vin Bch Mai thc hin trn 200 bnh n nm
2009 cho tlcc nhm thuc c sdng nh sau
- Tlbnh nhn c iu trbng metformin l cao nht (73%).
- Tlbnh nhn c iu trbng sulfonamide/dn xut ure l 72,2%.
7/21/2019 Phn Tch Hot ng Phn Ph i Thuc Ca Cng Ty C Phn Traphaco Giai on 2010 - 2012
23/65
14
- Tlbnh nhn iu trbng nhm c chalpha glucosidasel 24,3%.
- T l bnh nhn c dng thuc phi hp gia rosiglitazon v
metformin l 7,5%.
- Tlbnh nhn c dng thiazolidinedion l 1,5% [8].
Nghin cu ca Kong Chunny vthc trng sdng thuc T typ 2
ti khoa ni tit v T bnh vin Bach Mai thc hin trn 200 bnh n vo
nm 2008 cho thy:
- Tlbnh nhn c sdng insulin l cao nht (95,5%).
- Tlbnh nhn c sdng biguanid l 34%.
- Tlbnh nhn c sdng sulfonamide/ dn xut ure l 21,5%.
- Tlbnh nhn c sdng c chalpha glucosidase l 20% [6].
b. Cc nghin cu vnhp khu thuc ti Vit Nam
Nghin cu Phn tch c cu thuc thnh phm nhp khu giai on
2006-2010 ca Chu Quc Thnh trn c scc dliu vthuc nhp khu t
Tng cc Hi quan. Nghin cu tp trung kho st vc cu thuc nhp khutheo xut x, theo phn loi ATC, theo c quan gii phu...[5].
Nghin cu Phn tch thc trng nhp khu cc thuc khng khun
trong giai on 2006-2010 ca L ThPhng Hoa cng da trn c sd
liu vthuc nhp khu tTng cc Hi. Nghin cu tp trung kho st quan
vc cu nhp khu thuc khng sinh theo xut x, theo hot cht, theo nhm
thuc v theo hn bo hc quyn [9].
7/21/2019 Phn Tch Hot ng Phn Ph i Thuc Ca Cng Ty C Phn Traphaco Giai on 2010 - 2012
24/65
15
Chng 2. I TNG V PHNG PHP NGHIN CU
2.1. i tng nghin cu
i tng nghin cu ca ti l ton bcc thuc thnh phm iu
trTnhp khu vo Vit Nam trong giai on tnm 2006ti nm 2011.
2.2. Thi gian v a im nghin cu
o Thi gian nghin cu:
Nghin cu c thc hin trong thi gian t1/2/2013 ti 21/5/2013.
o a im nghin cu:
Bmn Qun l v kinh tDc - i hc Dc H Ni
Phng Qun l gi thuc - Cc Qun l Dc - BY t
2.3. Thit knghin cu
Thit knghin cu m t.
2.4. Ni dung nghin cu
o Kho st c cu v xu hng nhp khu cc nhm thuc iu trT giai
on 2006-2011.o Kho st c cu v xu hng nhp khu cc hot cht iu trT giai
on 2006-2011.
o Kho st c cu v xu hng nhp khu cc thuc iu trT theo quc
gia xut xgiai on 2006-2011.
2.5. Cc ch snghin cu
o Gi trKNNK v ttrng gi trKNNK ca cc nhm thuc, hot cht vca cc quc gia xut khu thuc iu trT vo Vit Nam.
o Slng v ttrng slng sng k (SK) ca cc nhm thuc, hot
cht v ca cc quc gia xut khu thuc iu trT vo Vit Nam.
o S lng v t trng tng s liu DDD trong mi nm ca cc nhm
thuc, hot cht v ca cc quc gia xut khu thuc iu tr T vo
Vit Nam.
7/21/2019 Phn Tch Hot ng Phn Ph i Thuc Ca Cng Ty C Phn Traphaco Giai on 2010 - 2012
25/65
16
- Tng sliu DDD nhp khu ca mt hot cht trong mi nm c
tnh theo cng thc:
Tng sliu DDD =
- Tng s liu DDD nhp khu ca nhm thuc = tng s liu DDD
nhp khu ca cc hot cht trong nhm
2.6. Thu thp v lm sch dliu
D liu nhp khu thuc lu tr ti Tng Cc hi quan Vit Nam t
1/1/2006 ti 31/12/2011 c thu thp v xl theo quy trnh:
Hnh 2.1. S xl sliu
Gii thch quy trnh:
Bc 1: Sng lc dliu vthuc thnh phm
D liu ban u do Tng cc Hi quan Vit Nam cung cp bao gm
tng t nhp hng trong nm ca nhiu nhm hng khc nhau (thuc thnh
D liu thuc nhpkhu ca cc Hi quan
D liu thuc thnhphm
D liu thuc thnhphm hon chnh
D liu ban u v
thuc iu tr T
D liu thuc iu trT hon thin
Sng lc dliu vthuc thnh phm
Bsung mc hot cht
(nu cn)
Gn m ATC, liuDDD v SK cho cc
thuc nghin cu
Sng lc dliu vthuc iu trT
7/21/2019 Phn Tch Hot ng Phn Ph i Thuc Ca Cng Ty C Phn Traphaco Giai on 2010 - 2012
26/65
17
phm, nguyn liu lm thuc, thuc th y, ha cht st khun,...). Do ,
ph hp vi i tng nghin cu ca ti l thuc thnh phm, chthng
tin v thuc thnh phm (m hng 3004) c chit tch v a vo nghin
cu.
Bc 2: Bsung thng tin vhot cht (nu cn)
Trong dliu ban u ti Tng cc Hi quan, thng tin vhot cht c
thkhng c, hoc khng y . Do , cn bsung thng tin ny do thng
tin hot cht l thit yu cho ni dung phn tch ca nghin cu.
hn chcc sai sc thxy ra, thng tin c tra cu ti hai c s
dliu c lp v cha vo nghin cu khi c snht qun gia hai c s
ny.
Bc 3: Sng lc dliu thuc iu tri tho ng
Sng lc dliu tt ccc thuc m hot cht tng ng c m bc 2 l
A10 theo phn loi ATC/WHO (Cc thuc s dng trong iu tr bnh
T).Danh mc hot cht a vo nghin cu c trnh by bng 2.1.
Bng 2.1.Danh mc cc hot cht iu trT trong nghin cu
Tn hot cht M ATC Tn hot cht M ATCAcarbose A10BF01 Insulin A10A
Benfluorex A10BX06 Metformin A10BA02
Chlorpropamid A10BB02 Pioglitazon A10BG03
Glibenclamid A10BB01 Repaglind A10BX02Glibenclamid v Metformin A10BD02 Rosiglitazon A10BG02
Gliclazid A10BB09 Rosiglitazon v Metformin A10BD03
Gliclazid v Metformin A10BD02 Glimepirid v Metformin A10BD02
Glimepirid A10BB12 Pioglitazon v Metformin A10BD05
7/21/2019 Phn Tch Hot ng Phn Ph i Thuc Ca Cng Ty C Phn Traphaco Giai on 2010 - 2012
27/65
7/21/2019 Phn Tch Hot ng Phn Ph i Thuc Ca Cng Ty C Phn Traphaco Giai on 2010 - 2012
28/65
19
Chng 3. KT QUNGHIN CU3.1. Gi trKNNK v slng SK cc thuc iu trT nhp khu
vo Vit Nam (2006-2011)3.1.1.Gi trKNNK cc thuc iu trT nhp khu (2006-2011)
Gi trKNNK v ttrng KNNK thuc iu trT trn tng gi tr
KNNK thuc nhp khu giai on 2006-2011 c thhin bng 3.1.
Bng 3.1. Gi trKNNK v ttrng gi trKNNK thuc iu trT
(2006-2011)
2006 2007 2008 2009 2010 2011KNNK thuc T
(triu USD)15,05 18,41 25,44 27,84 35,43 40,98
Tng KNNK(triu USD)
513,68 690,52 829,52 1051,04 1162,44 1328,21
Ttrng KNNK(%)
2,93 2,67 3,07 2,65 3,05 3,09
Tbng kt qutrn, ta thy:
Gi trKNNK thuc iu trT tng ng k trong thi gian khost. Cth, gi trKNNK tng 2,7 ln: t15,05 triu USD (2006) ln 40,98
triu USD (2011). Trong khi , ttrng gi trKNNK thuc iu trT so
vi tng KNNK thuc nhp khu tng i n inh: t trng cc thuc ny
chim khong t2,7-3,1% tng gi trKNNK ca thuc nhp khu.
3.1.2.Slng SK ccthuc iu trT nhp khu (2006-2011)
Tng s lng s ng k (SK) ca tt c cc thuc iu tr Tnhp khu vo Vit Nam c thhin trong bng 3.2 bn di.
Bng 3.2. Slng SK cc thuc iu trT nhp khu (2006-2011)
2006 2007 2008 2009 2010 2011
Slng SK 126 141 151 155 182 186
Tbng kt qutrn ta thy:
7/21/2019 Phn Tch Hot ng Phn Ph i Thuc Ca Cng Ty C Phn Traphaco Giai on 2010 - 2012
29/65
20
Tng slng SK ca 16 hot cht c nghin cu trong ti tng
dn qua tt c cc nm. Tng mnh nht l tng 27 SK mt nm (2009-
2010). V tng t nht chtng4 SK mt nm (2008-2009 v 2010-2011).
3.2. C cu v xu hng NK cc nhm thuc iu trT (2006-2011)
By nhm thuc iu tr T theo phn loi ATC c a vo
nghin cu bao gm: insulin (A10A), cc biguanid (A10BA), sulfolnamid/
dn cht ure (A10BB), thuc iu tr T ng ung dng kt hp
(A10BD), cc cht c ch alphaglucosidase (A10BF), cc thiazolindinion
(A10BG) v cc thuc hng huyt khc ngoi tr insulin (A10BX). C
cu nhp khu cc nhm thuc ny c kho st da trn ba chs: gi tr/t
trng KNNK, tng sliu/ttrng slng liu DDD v slng SK.
3.2.1.Kho st da trn gi trkim ngch nhp khu
C cu nhp khu cc nhm thuc iu trT theo gi trKNNK v
ttrng gi trKNNK c trnh by trong hnh 3.1. Ttrng gi trKNNK
ca mt nhm thuc trong mt nm c tnh bng tlphn trm gia gitrKNNK ca nhm thuc trong nm trn tng gi trKNNK ca tt ccc
thuc iu trT trong nm.
Thnh 3.1, v sliu chi tit ti phlc 1, phlc 2, ta thy:
Trong giai on 2006-2011, cc nhm thuc c ttrng gi trKNNK
ln nht l: sulfonamid/dn xut ure (37,0-48,4%), biguanid (17,8-24,2%) v
insulin (16,2-27,7%). Trong 3 nhm ny, t trng gi trKNNK ca nhmsulfonamid/dn xut ure c xu hng tng trong giai on 2006-2008 (nm
2008 t ti gn 50% tng gi trKNNK cc thuc iu trT) v gim
trong giai on 2008-2011. Trong khi , hai nhm cn li cho thy xu hng
ngc li: tsau nm 2008, t trng KNNK ca hai nhm thuc ny c xu
hng tng dn.
7/21/2019 Phn Tch Hot ng Phn Ph i Thuc Ca Cng Ty C Phn Traphaco Giai on 2010 - 2012
30/65
21
i vi cc nhm thuc khc, kt qucho thy: ttrng KNNK tng
nhm cht c chalpha glucosidase v cc thuc T ng ung dng kt
hp. Cc nhm thuc cn li c xu hng gim t trng, c bit l nhm
thiazolidinedion: gim t10.5% (2006) xung cn 2% (2011).
Hnh 3.1 Gi trv ttrng KNNK cc nhm thuc iu trT3.2.2.Kho st da trn slng sng k
C cu nhp khu cc nhm thuc iu trT ti Vit Nam theo s
lng SK c thhin hnh 3.2.
Thnh 3.2, v sliu cthti phlc 3, ta thy:
Trong giai on 2006-2011,cc nhm thuc iu trT c s lng
SK nhiu nht l sulfonamid/dn xut ure (47-76 SK), biguanid (29-43
0
2
4
6
8
10
12
14
16
18
Triu
USD
0.0%
10.0%
20.0%
30.0%
40.0%
50.0%
60.0%
Biguanid
Sulfonamid/dnxut ure
Thuc Tng ungdng kt hp
Cht c chalphaglucosidase
Thiazolidindion
Cc cht hng huytkhc tr insulin
Insulin
7/21/2019 Phn Tch Hot ng Phn Ph i Thuc Ca Cng Ty C Phn Traphaco Giai on 2010 - 2012
31/65
22
SK), insulin (17-34 SK) v thiazolidindion (17-27 SK). Trong bn
nhm, ngoi tr thiazolidindion, cc nhm cn li c xu hng tng dn s
lng SK.
i vi cc nhm thuc khc, kt qucho thy: cc thuc iu trT
ng ung dng kt hp c slng SK tng dn t6 SK (2006) ti 13
SK (2010). Hai nhm cn li (cht c chalpha glucosidase v cc thuc h
ng huyt khc ngoi trinsulin) c rt t SK (khng qu 3 SK/nhm).
Hnh 3.2 Slng SK ca cc nhm thuc iu trT (2006-2011)
3.2.3.Kho st da trn tng sliu DDD
T trng tng s liu DDD ca mt nhm thuc c tnh bng t l
phn trm gia tng sliu DDD ca nhm thuc trn tng sliu DDD ca
tt ccc thuc iu trT. Ngoi trcc thuc iu trT ng ung
0
10
20
30
40
50
60
70
80
Nm
2006
Nm
2007
Nm
2008
Nm
2009
Nm
2010
Nm
2011
Biguanid
Sulfonamid v dn xuture
Thuc T ng ungdng kt hp
Cht c ch alphaglucosidase
Thiazolidindion
Cc cht h ng huytkhc tr insulin
Insulin
7/21/2019 Phn Tch Hot ng Phn Ph i Thuc Ca Cng Ty C Phn Traphaco Giai on 2010 - 2012
32/65
23
dng kt hp (A10BD), tt ccc nhm thuc cn li c thtnh ton c
theo chsny.
Tng sliu DDD ca cc nhm thuc cn li c tnh ton v c
thhin hnh 3.3.
Hnh 3.3. Tng sliu v ttrng tng sliu DDD ca cc nhm thuc
iu trT (2006 2011)
Thnh 3.3, v sliu chi tit ti phlc 4, phlc 5, ta thy:
Bn nhm thuc c t trng tng s liu DDD ln nht l:
sulfonamid/dn xut ure (57,07-76,06%), biguanid (11,42-31,93%), insulin
(5,27-8,33%) v thiazolidinedion (1,93-4,09%). Tip tc phn tch su hn
bn nhm cht ny:
0
20
40
60
80
100
120
140
160
180
Triu
liu
0.00%
10.00%
20.00%
30.00%
40.00%
50.00%
60.00%
70.00%
80.00%
Biguanid
Sulfonamid/dnxut ure
Thuc Tng ungdng kt hp
Cht c chalphaglucosidase
Thiazolidindion
Cc cht hng huytkhc tr insulin
Insulin
7/21/2019 Phn Tch Hot ng Phn Ph i Thuc Ca Cng Ty C Phn Traphaco Giai on 2010 - 2012
33/65
24
- i vi hai nhm sulfonamid/dn cht ure v biguanid:
T 2006-2008: sulfonamid/dn cht ure tng mnh v t trng
(57,07%-76,06%) trong khi biguanid gim mnh vttrng (31,67%-
11,42%).
T 2008-2010: biguanid tng mnh v t trng (11,42%-
19,62%) trong khi sulfonamid/dn cht ure gim mnh v t trng
(76,06%-66,50%)
- i vi hai nhm cn li:
Tnm 2007, ttrng Insulin c xu hng tng lin tc (5,27%-
8,74%) trong khi thiazolidinedion n nh mc 3-4%, chgim xung
di 2% vo nm 2011.
Cc nhm khc (cc cht c chalphaglucosidase v cc cht h
ng huyt khc ngoi trinsulin) c ttrng slng liu DDD rt
nh(< 1,3%).
3.3.
C cu v xu hng nhp khu cc hot cht iu trTDanh mc cc hot cht iu trT nghin cu trnh by trong bng
2.1. C cu nhp khu cc hot cht ny c kho st da trn ba chs: gi
tr/ttrng KNNK, tng sliu/ttrng slng liu DDD v slng SK.
3.3.1.Kho st da trn gi trkim ngch nhp khu
C cu nhp khu cc hot cht iu trT ti Vit Nam theo gi trv
ttrng gi trKNNK c thhin hnh 3.4.Ttrng KNNK ca mt hot cht c tnh bng tlphn trm gia
gi trKNNK ca hot cht so vi tng gi trKNNK ca tt ccc hot
cht. Thnh 3.4, v chi tit sliu phlc 6, phlc 7, ta thy:
Cc hot cht c t trng KNNK ln nht l gliclazid (22,6-34,5%),
metformin (17,8-24,2%), insulin (19,3-24,7%) v glimepirid (8,5-14,9%).
7/21/2019 Phn Tch Hot ng Phn Ph i Thuc Ca Cng Ty C Phn Traphaco Giai on 2010 - 2012
34/65
25
Tm hiu su hn v xu hng ca hai nhm thuc l gliclazid v
metformin:
- Trong giai on 2006-2007: gliclazid c t trng KNNK tng t
22,6%-34,5% trong khi metformin c ttrng KNNK gim t24,2%-
17,8%.
- Trong giai on 2007-2008: metformin c t trng KNNK tng
(17,8%-18,3%), trong khi gliclazid c t trng KNNK gim (34,5%-
30,9%).
- Trong giai on 2009-2010: metformin c t trng KNNK tng
(18,9%-22,9%) trong khi gliclazid c t trng KNNK gim (33,4%-
28,3%).
Xt vgi trKNNK, trong giai on t2006-2011, cc hot cht c
gi trKNNK tng lin tip l: gliclazid (3,64-11,08 triu USD), insulin (2,43
-10,10 triu USD), metformin tng t(3,64-8,71 triu USD).
Trong cc hot cht cn li:- Benfluorex c ttrng KNNK gim t2,23% (2006) n 0%(2010).
- Rosiglitazon c ttrng KNNK gim t7,26% (2006) n 0%(2011).
- Hot cht dng kt hp gia rosiglitazon v metformin c t trng
KNNK gim t1,69% (2010) xung 0%(2011).
Xu hng nhp khu cc hot cht iu trTtheo KNNK c th
hin trong hnh 3.4 di y.
7/21/2019 Phn Tch Hot ng Phn Ph i Thuc Ca Cng Ty C Phn Traphaco Giai on 2010 - 2012
35/65
26
Hnh 3.4. KNNK ca cc hot cht iu trT v ttrng (2006-2011)
3.3.2.Kho st theo slng sng k
C cu nhp khu cc hot cht iu trT theo slng SK c
thhin trong hnh 3.5 di y.
0
2
4
6
8
10
12
Tr
iu
USD
0.00%
5.00%
10.00%
15.00%
20.00%
25.00%
30.00%
35.00%
40.00%
acarbose
benfluorex
chlorpropamid
glibenclamid
glibenclamid vmetformin
gliclazid
gliclazid vmetformin
glimepirid
insulin
metformin
pioglitazon
repaglind
rosiglitazon
rosiglitazon vmetformin
glimepirid vmetformin
pioglitazon vmetformin
7/21/2019 Phn Tch Hot ng Phn Ph i Thuc Ca Cng Ty C Phn Traphaco Giai on 2010 - 2012
36/65
27
Hnh 3.5. Slng SK ca cc hot cht iu trT nhp khu
Thnh 3.5 v chi tit sliu phlc 8 ta thy:
Bn hot cht c slng SK nhiu nht l meformin (29-43 SK),
glimepirid (17-46 SK), gliclazid (16-24 SK) v insulin (18-34 SK).
Nhn xt vxu hng bin ng slng SK ca tng hot cht trn nh
sau:
- Trong giai on 2008-2011: metformin c xu hng tng slng (t
30-43 SK), glimepirid c xu hng tng slng SK(29-46 SK).
- Trong giai on 2007-2011: insulin tng gp i slng SK (17-
34 SK), gliclazid c slng SK tng i n nh (22-24 SK).
Vi cc hot cht cn li: rosiglitazon c slng SK gim 8-4 SK
(2006-2010) v khng cn SK no nm 2011. Benfluorex ch c duy nht
mt SK trong bn nm (2006-2009),v khng c SK no nm 2010 v
2011.
0
5
10
15
20
25
30
35
40
45
50
Nm
2006
Nm
2007
Nm
2008
Nm
2009
Nm
2010
Nm
2011
acarbose
benfluorex
chlorpropamid
glibenclamid
glibenclamid v metformin
gliclazid
gliclazid v metformin
glimepirid
insulin
metformin
pioglitazon
repaglind
rosiglitazon
rosiglitazon v metformin
glimepirid v metformin
pioglitazon v metformin
7/21/2019 Phn Tch Hot ng Phn Ph i Thuc Ca Cng Ty C Phn Traphaco Giai on 2010 - 2012
37/65
28
3.3.3.Kho st theo tng sliu DDD
Ttrng sliu DDD ca cc hot cht c tnh bng tlphn trm
gia slng liu DDD ca mt hot cht so vi tng slng liu DDD ca
tt ccc hot cht c tnh ton (A10BD khng c tnh ton liu DDD).
Ngoi trcc hot cht iu trT dng kt hp (A10BD), slng
liu DDD v ttrng ca cc hot cht iu trT c thhin trong hnh
3.6 di y.
Hnh 3.6. Tng sliu DDD ca cc hot cht iu trT v ttrng
0
10
20
30
40
50
60
70
80
90
Triu
liu
0.00%
5.00%
10.00%
15.00%
20.00%
25.00%
30.00%
35.00%
40.00%
45.00%
50.00% acarbose
benfluorex
chlorpropamid
glibenclamid
glibenclamide vmetformingliclazid
gliclazide vmetforminglimepirid
insulin
metformin
pioglitazon
repaglind
rosiglitazon
rosiglitazon vmetforminglimepirid vmetforminpioglitazon vmetformin
7/21/2019 Phn Tch Hot ng Phn Ph i Thuc Ca Cng Ty C Phn Traphaco Giai on 2010 - 2012
38/65
29
Thnh 3.6 v chi tit sliu ti phlc 9, phlc 10, ta thy :
Ba hot cht c t trng s liu DDD ln nht l gliclazid (29,05-
45,59%), metformin (11,42- 31,93%), glimepirid (8,04- 29,38%). Xt vxu
hng bin ng ttrng cc hot cht ny thy rng :
- i vi gliclazid: trong giai on 2006-2009 c t trng tng s liu
DDD tng t29,05%-45,59% v gim t45,59%-34,44% trong giai
on t2009-2011.
- i vi glimepirid: hot cht ny c xu hng tng t trng tng s
liu DDD t8,04% (2007) ti 29,38% (2011).
- i vi metformin: hot cht ny c t trng tng s liu DDD gim
mnh t 31,93-11,42% (2007-2008) v tng mnh t 11,42-19,62%
(2008-2010).
- c bit, giai on 2007-2008: t trng tng s liu DDD: gliclazid
tng (37,42-40,54%) v glimepirid tng (8,04-22,25%) trong khi
metformin gim mnh (31,93-11,42%).Trong cc hot cht cn li: glibenclamid c xu hng gim ttrng
sliu DDD t11,93-3,96% trong giai on 2006-2010. Insulin c xu hng
tng ttrng sliu DDD t5,79% (2006) ti 8,33% (2011). Benfluorex v
rosiglitazon u gim dn ttrng tng sliu DDD v0. (benfluorex c t
trng gim v0 nm 2010, rosiglitazon c ttrng gim v0 nm 2011).
3.4.
C cu v xu hng nhp khu cc thuc iu tri tho ngtheo quc gia xut x(2006-2011)
Cc thuc iu trT nhp khu ti Vit Nam c ngun gc t23
quc gia trn ton th gii. Gm c Argentina, Bangladesh, Canada, Trung
Quc, Cyprus, an Mch, Php, c, n , Indonesia, , Hn Quc,
Malaysia, Pakistan, Ba Lan, Singapo, Ty Ban Nha, i Loan, ThNh K,
Anh, M, Israel, c.
7/21/2019 Phn Tch Hot ng Phn Ph i Thuc Ca Cng Ty C Phn Traphaco Giai on 2010 - 2012
39/65
30
C cu nhp khu tcc quc gia ny c kho st da trn ba chs:
gi tr/t trng KNNK, v slng SK. Ngoi ra cc quc gia c t trng
KNNK ln cng c kho st cthhn.
3.4.1.Kho st theo kim ngch nhp khu.
Ttrng KNNK ca mt quc gia c tnh bng tlphn trm gia
gi trKNNK ca quc gia so vi tng gi trKNNK ca tt ccc quc
gia.
Thnh 3.7 v chi tit sliu ti phlc 11, phlc 12, ta thy:
Bn quc gia c t trng KNNK ln nht ln lt l Php (42,1-
48,2%), an mch (8,5-16,3%), n (7,3-13,4%), (6,0-11,7%). Nhn xt
ta thy:
- Giai on 2009-2011: n c xu hng tng dn ttrng KNNK t
7,4-13,4%, tng t6-7,6%, trong khi ttrng KNNK tPhp c xu
hng gim dn 48,1-42,1%.
- Trong giai on 2006 - 2011, Php c ttrng KNNK gim t48,2%-42,1%, tuy nhin gi tr KNNK ca Php li tng mnh 7,25-17,27
triu USD.
- Trong giai on nghin cu ttrng KNNK ca an Mch ln xung
qua tng nm, tuy nhin gi tr KNNK li tng dn 1,56-6,69 triu
USD.
Trong cc quc gia cn li, Ba Lan c t trng KNNK tng dn t3,4%-7,1% giai on (2006-2008) v gim dn t7,1-2,7% giai on (2008-
2011). Hn Quc c t trng KNNK thp nhng l quc gia duy nht c t
trng KNNK tng dn sau 6 nm t1,7%-3,9% (2006-2011).
Kim ngch nhp khu v ttrng KNNK tcc quc gia c thhin
trong hnh 3.7 di y.
7/21/2019 Phn Tch Hot ng Phn Ph i Thuc Ca Cng Ty C Phn Traphaco Giai on 2010 - 2012
40/65
31
Hnh 3.7. Gi trKNNK v ttrng gi trKNNK theo quc gia xut x
Thnh 3.7 trn ta thy:
Php l quc gia c gi trKNNK v tlKNNK cao nht trong tt c
cc quc gia trong c6 nm t2006 n 2011. V vy ta nghin cu khn
vc cu nhp khu mt sbit dc tPhp.
KNNK mt sbit dc tc ttrng ln nht tPhp c trnh by
trong bng 3.3 di y.
0
2
4
6
8
10
12
14
16
18
20
Tr
iu
USD
0.0%
10.0%
20.0%
30.0%
40.0%
50.0%
60.0% Argentina
Bangladesh
Canada
Trung Quc
Cyprus
an Mch
Php
c
n
Indonesia
Hn Quc
Malaysia
Pakistan
Ba Lan
Singapo
Ty Ban Nha
a Loan
Th nh k
Anh
M
Israel
c
7/21/2019 Phn Tch Hot ng Phn Ph i Thuc Ca Cng Ty C Phn Traphaco Giai on 2010 - 2012
41/65
32
Bng 3.3.Gi trKNNK ca mt sbit dc iu trT c xut xtPhp.
Tn Bit dc 2006 2007 2008 2009 2010 2011
DiamicronKNNK
(Triu USD)3,04 5,57 6,51 8,15 8,84 9,67
Ttrng % 41,9 63,4 58,2 60,9 57,8 56,0
GlucophageKNNK
(Triu USD)2,85 2,04 3,28 3,54 4,70 5,75
Ttrng % 39,3 23,2 29,3 26,4 30,7 33,3
GlucovanceKNNK
(Triu USD)0,64 0,76 0,95 1,23 1,40 1,85
Ttrng % 8,8 8,6 8,5 9,2 9,2 10,7
KNNK tPhp
KNNK(Triu USD)
7,25 8,79 11,19 13,39 15,29 17,27
Tbng trn ta thy:
Hai bit dc Diamicron v Glucophage chim hn 86% tng KNNK
ca cc bit dc c xut xPhp.
Trong Diamicron vi hot cht gliclazid ttrng chim 41,9- 63,4%
tng KNNK ca cc thuc tPhp v chim ti 20,2-30,3% ttrng KNNKca tt ccc thuc iu tr T nhp khu vo thtrng Vit Nam. ng
th 2 l bit dc Glucophage (hot cht metformin) vi t trng KNNK
23,2-39,3% tng KNNK ca cc thuc c ngun gc tPhp. Cao th3 trong
cc bit dc nhp khu tPhp l Glucovance (kt hp gia glibenclamid v
metformin) vi t trng 8,8 10,7% tng KNNK t Php v ang c xu
hng tng ln (8,8 % nm 2006 ti 10,7% nm 2011).3.4.2.Kho st theo slng sng k
Cc quc gia c SK nhiu nht Vit Nam l n (41-78 SK),
Hn Quc (10- 20 SK), Php (9-14 SK), c (11-13 SK), an Mch (8-
10 SK).Nhn xt thnh 3.8 v chi tit sliu ti phlc 13, ta thy:
7/21/2019 Phn Tch Hot ng Phn Ph i Thuc Ca Cng Ty C Phn Traphaco Giai on 2010 - 2012
42/65
33
- Slng SK tn v Hn Quc ang c xu hng gia tng, n
tng t 53- 78 SK (2008-2011), Hn Quc c slng SK tng
gp i trong 6 nm t10-20 SK (2006-2011).
- Php, c v an Mch c slng SK tng i n nh. Php (9-
14 SK), c (11-13SK), an Mch (8-10SK).
Trong nhm cc quc gia cn li Pakistan l quc gia c SK tng
nhanh t3 SK (2009) ti 13 SK (2011)(gp hn 4 ln).
S lng SK cc thuc iu tr T theo quc gia c th hin
trong hnh 3.8 di y:
Hnh 3.8. Slng SK tcc quc gia c thuc iu trT Vit
Nam giai on 2006-2011
0
10
20
30
40
50
60
70
80
90
Nm 2006 Nm 2007 Nm 2008 Nm 2009 Nm 2010 Nm 2011
Argentina
Bangladesh
Canada
Trung Quc
Cyprus
an Mch
Php
c
n
Indonesia
Hn Quc
Malaysia
Pakistan
Ba Lan
Singapo
Ty Ban Nha
a LoanTh nh k
Anh
M
Israel
c
7/21/2019 Phn Tch Hot ng Phn Ph i Thuc Ca Cng Ty C Phn Traphaco Giai on 2010 - 2012
43/65
34
Chng 4. BN LUN
4.1.
Bn lun vkt qunghin cu
4.1.1.Xu hng chung vnhp khu cc thuc iu tri tho ng
Trong thi gian thc hin kho st (2006-2010), gi trKNNK ca cc
thuc iu trT Vit Nam lin tc tng: t15,05 triu USD (2006) ti
40,98 triu USD (2011) (tng gp 2,7 ln). Xt v t trng KNNK, t trng
KNNK cc thuc iu trT duy tr khong 3%, ph hp vi m hnh
bnh TVit Nam (tlhin mc bnh T ti Vit Nam l 3%) [24].
S lng SK cc thuc iu trT nhp khu vo Vit Nam tng
dn qua cc nm: mc tng mnh nht ghi nhn giai on 2009-2010 (tng
27 SK), trong i vi ring hot cht pioglitazon, mc tng l 11
SK.
4.1.2.Xu hng nhp khu cc nhm thuc iu tri tho ng
Ba nhm thuc iu trT c nhp khu nhiu nht (v t trnggi trKNNK, t trng tng sliu DDD, s lng SK) vo Vit Nam l:
biguanid, sulfonamide/dn xut ure, v insulin. Kho st kcho thy gi tr
KNNK, s lng SK, tng s liu DDD ca cba nhm thuc ny c xu
hng tng ln trong giai on nghin cu. Cba nhm thuc ny u c
khuyn co s dng sm trong cc phc iu tr T ca IDF v ca
ADA/EASD.Nhm thiazolidinedion khng tng nhiu v gi tr KNNK, t trng
KNNK lin tc gim, c bit, vo nm 2011 gim xung mc di 2%. Hai
hot cht ca nhm thuc ny c nhp khu vo th trng Vit Nam l
rosiglitazon v pioglitazon. Trong , hot cht rosiglitazon b Cc Qun
l dc Vit Nam cho ngng nhp khu vo 22/03/2011, v tc dng phgy
nguy c tim mch v au tht ngc [7].
7/21/2019 Phn Tch Hot ng Phn Ph i Thuc Ca Cng Ty C Phn Traphaco Giai on 2010 - 2012
44/65
35
Theo cc phc iu tr ca IDF, ADA/EASD, metformin (thuc
nhm biuanid) l u tin hng u kim sot ng huyt bnh nhn
T typ 2. Tuy nhin, ttrng gi trKNNK v ttrng tng sliu DDD
nhp khu ca nhm thuc biguanid thp hn ca nhm thuc
sulfonamide/dn xut ure, iu ny khc so vi nghin cu ca o Mai
Hng, ca Kong Chunny v ca Marta Baviera [6],[8],[10].
Tlnhp khu sulfonamide/dn xut ure cao hn biguanid ging vi
nghin cu ca B.Hanko v cng s v vic s dng thuc T ti
Hungary. Tuy nhin nghin cu ny c thc hin vo giai on 1998
2002, khc vi giai on nghin cu 2006 2011 trong kha lun [13].
4.1.3.Xu hng nhp khu cc hot cht iu tri tho ng
Cc hot cht c ttrng gi trKNNK, slng SK v ttrng tng
s liu DDD ln nht trong giai on nghin cu l gliclazid, metfomin,
insulin, glimepirid. Cc hot cht ny cng thu c cc nhm hot cht c t
trng gi trKNNK ln nht trong thi gian kho st.Nhn xt vsph hp gia c cu nhp khu v cc thng tin y hc
ca mt shot cht iu trT:
a. Benfluorex:
Benfluorex l thuc iu trT thuc nhm A10BX theo phn loi
ATC/WHO. Ti Vit Nam, hot cht ny chc mt sng k duy nht ca
Mediator (Php).Kho st gi trKNNK ca hot cht ny ta thy:
- Trong giai on t2006 2008, gi trKNNK ca benfluorex tng lin
tc t335.000 USD ti 454 nghn USD.
- Tuy nhin, vo nm 2009, KNNK ca benfluorex gim nhxung cn
413.000 USD. Ti nm 2010, benfluorex khng cn c nhp khu vo Vit
Nam
7/21/2019 Phn Tch Hot ng Phn Ph i Thuc Ca Cng Ty C Phn Traphaco Giai on 2010 - 2012
45/65
36
Tm hiu cc thng tin lin quan ti hot cht ny, chng ti nhn thy
c slin quan gia vic NK ca benfluorex v cc thng tin y hc, cthl:
- Vic gim nhgi trKNNK ca benfluorex lin quan ti quyt nh
thu hi Mediator ca C quan qun l thuc Chu u (European Medicines
Agency) do nghi ngv nguy c gy bnh van tim ca benfluorex trn bnh
nhn T typ 2[19],[21].
- Vic ngng nhp khu benfluorex lin quan n quyt nh s260/Q-
QLD vvic rt sng k i vi bit dc Mediator ti Vit Nam.
b. Rosiglitazon.
Rosiglitazon l mt trong hai hot cht thuc nhm thiazolidinedion
c nhp khu vo Vit Nam (hot cht cn li l Pioglitazon).Nm 2010,
rosiglitazon nhp khu vo Vit Nam vi cc bit dc l Avandia, Rogelin,
Rosiglen, Rapzole. Ngoi ra, Vit Nam cn c Avandamet l bit dc ca
hot cht rosiglitazon kt hp vi metformin.
Kho st gi trKNNK ca hot cht rosiglitazon ta thy:- Trong giai on 2006 2007, gi trKNNK gim 6,3 ln t1,1 triu
USD xung cn 173.000 USD.
- Trong giai on 2009 2010, gi trKNNK gim khong 5,8 ln t
475.000 USD xung cn 82.000 USD. Trong khi , hot cht cng nhm l
pioglitazon li c s gia tng ng k v gi tr KNNK (tng 2,3 ln t
589.000USD n 1,35 triu USD).- Nm 2010, rosiglitazon khng cn c nhp khu vo Vit Nam.
Trong khi t trng KNNK ca pioglitazon li ng th ba trong s cc
hot cht c gi trKNNK cao nht.
Tm hiu cc thng tin lin quan ti hot cht ny, chng ti nhn thy
c slin quan gia vic NK rosiglitazon v cc thng tin y hc, cth:
7/21/2019 Phn Tch Hot ng Phn Ph i Thuc Ca Cng Ty C Phn Traphaco Giai on 2010 - 2012
46/65
7/21/2019 Phn Tch Hot ng Phn Ph i Thuc Ca Cng Ty C Phn Traphaco Giai on 2010 - 2012
47/65
38
chng trng, scnh tranh ca cc quc gia sn xut thuc generic c nh
hng nht nh ti cc quc gia sn xut thuc pht minh.
4.2.
Hn chca ti
4.2.1.Hn chvphng php nghin cu
Vphng php nghin cu, ti c mt shn chsau:
Mt trong nhng ch s nghin cu ti la chn l tng s liu
DDD. Vic nghin cu da trn chsny c hn chl DDD l liu c
tnh ton cho ngi trng thnh, do ,khi sdng liu DDD nh gi
tiu th thuc ni chung th thng khng hon ton chnh xc. Tuy nhin,
im ny t nh hng khi nh gi tiu ththuc iu trT do bnh T
thng t gp trnh. Bn cnh , liu thc tsdng li gn ging vi
liu DDD ca cc hot cht.
Dliu vthuc nhp khu khng nh gi c ht tnh hnh sdng
thuc trong thc t, do kt quca nghin cu khng c gi trcho vic
ngoi suy thc trng sdng thuc iu trT ti Vit Nam.Giai on nghin cu cn ngn v khng c dliu vcc thuc NK
nm 2012 v vy c thcha nh gi chnh xc c vxu hng cc thuc
iu trT nhp khu ti Vit Nam.
Khng c dliu vcc thuc sn xut trong nc, do khng thso
snh v nh gi ton din vtiu ththuc iu trT ti Vit Nam.
Do hn ch v phn tch kt qu, cc hot cht trong nhm thucinsulin cha chit tch ring c, do nghin cu cha phn tch c xu
hng v c cu ca cc hot cht insulin nhp khu vo Vit Nam.
4.2.2.Hn chvdliu nghin cu
Dliu nghin cu khng c thng nht gia nhng trng dliu
nhp trong Microsoft Excel, thiu hot cht ca mt sthuc. Cc thiu st v
danh mc hot cht ny cn c bsung v kim tra li.
7/21/2019 Phn Tch Hot ng Phn Ph i Thuc Ca Cng Ty C Phn Traphaco Giai on 2010 - 2012
48/65
39
hn chnhng sai skhi bsung danh mc hot cht, tt ccc d
liu ngoi suy u c kim tra t nht hai ln ti hai c sdliu khc nhau
v cha vo nghin cu khi hai ngun thng tin l nht qun.
4.2.3.Hn chvbin gii kt qu
Do hn chca ngi nghin cu, cc so snh vsph hp gia vic
nhp khu thuc v cc phc iu trchda vo cc phc iu trT
ca nc ngoi m cha so snh vi cc phc trong nc.
Cc thng tin lin quan n cht lng, phn ng c hi hay thay i
hng dn iu trcn cha c cp nht y , do qu trnh bi n lun
cc xu hng nhp khu cn hn ch.
7/21/2019 Phn Tch Hot ng Phn Ph i Thuc Ca Cng Ty C Phn Traphaco Giai on 2010 - 2012
49/65
40
KT LUN V KIN NGH
1. Kt lun
Kt quca ti cho thy:
Gi trKNNK, slng SK v tng sliu DDD ca cc thuc iu
trT vo Vit Nam ngy cng tng. Trong :
Cc nhm thuc iu trT nhp khu c ttrng KNNK, slng
SK v t trng tng s liu DDD cao nht l sulfonamid /dn xut ure,
biguanid v insulin. Cc nhm thuc ny c gi trKNNK v slng SK
c xu hng tng dn trong giai on 2006- 2011. Xu hng ny l ph hp
so vi cc khuyn co viu trT trn thgii
Cc hot cht iu trT nhp khu vo Vit Nam c ttrng gi tr
KNNK, s lng SK, v t trng tng s liu DDD ln nht l gliclazid,
metfomin, glimepirid. Cc hot cht ny u l cc hot cht nm trong nhm
cc thuc c khuyn co sdng sm kim sot ng huyt.
n l quc gia c slng SK thuc iu trT ln nht nhngPhp mi l quc gia c ttrng gi trKNNK vo Vit nam l ln nht. Tuy
nhin, ttrng gi trKNNK ca Php c xu hng gim dn trong khi ca
n c xu hng tng dn.
Cc thng tin y hc v cc quyt nh qun l c tc ng quan trng
ti xu hng nhp khu, thhin qua vic gim ttrng nhp khu do thng
tin vphn ng c hi trng hp ca benfluorex v rosiglitazon.2. Kin nghv xut.
thun tin cho vic qun l v nghin cu cc thuc nhp khu vo
thtrng Vit Nam, xut Tng cc Hi Quan v Cc Qun l kt hp xy
dng chng trnh qun l cc thuc nhp khu vi y thng tin vqun
l xut nhp khu v thng tin vqun l dc.
7/21/2019 Phn Tch Hot ng Phn Ph i Thuc Ca Cng Ty C Phn Traphaco Giai on 2010 - 2012
50/65
41
nh gi ton din vthuc iu trT ti Vit Nam, chng ti
xut thc hin ti nghin cu vc cu v xu hng cc thuc iu tr
T c sn xut ti trong nc v ti vc cu v xu hng nhp khu
cc thuc insulin ti Vit Nam.
Cc doanh nghip nhp khu thuc iu trT vo Vit Nam nn cp
nht thng xuyn cc thng tin y hc (c bit l cc thng tin vcnh gic
dc), sthay i cc phc iu trT v cc quyt nh lin quan n
qun l thuc c thdon c cc xu hng nhp khu ph hp vi
tnh hnh bnh tt v cc thng tin y hc nh trng hp ca benfluorex v
rosiglitazon.
7/21/2019 Phn Tch Hot ng Phn Ph i Thuc Ca Cng Ty C Phn Traphaco Giai on 2010 - 2012
51/65
TI LIU THAM KHO
TING VIT:
1. BThu H (2009),Nghin cu thc trng bnh i tho ng iu tr
ti bnh vin a khoa tnh Bc Kn, Lun vnthc s, Trng i hc
Y Dc Thi Nguyn.
2. Bnh vin Bch Mai (2012),Hng dn chn on v iu trbnh ni
khoa, Nh xut bn Y hc, H Ni.
3. BY T (2011), Php chDc, Nh xut bn Gio Dc Vit Nam,
H Ni.
4. BY t(2010),Bnh hc, Nh xut bn y hc, H Ni.
5. Chu Quc Thnh (2009), Phn tch c cu thuc thnh phm nhp
khu giai on 2006-2008, Lun vn thc s, i hc Dc H Ni,
H Ni.
6. Chunny Kong (2008), Kho st thc trng sdng thuc iu tri
tho ng typ 2 ti khoa ni tit v i tho ng bnh vin BchMai, Lun vn thc sdc hc, i hc Dc H Ni, H Ni.
7. Cc Qun l Dc Vit Nam - BY t(2011), Quyt nh vng k,
sn xut, lu hnh, sdng thuc cha Rosiglitazone - S3886/QLD-
K.
8. o Mai Hng (2012),Nhn xt vic sdng thuc iu tri tho
ng dng ung ti khoa khm bnh - Bnh vin Bch Mai, Lun vnthc s, i hc Dc H Ni, H Ni.
9. L ThPhng Hoa (2011), Phn tch thc trng nhp khu cc thuc
khng khun trong giai on 2006-2010, Lun vn thc s, i hc
Dc H Ni, H Ni.
7/21/2019 Phn Tch Hot ng Phn Ph i Thuc Ca Cng Ty C Phn Traphaco Giai on 2010 - 2012
52/65
TING ANH:
10. Baviera Marta, Monesi Lara, Marzona Irene, et al. (2011), "Trends in
drug prescriptions to diabetic patients from 2000 to 2008 in Italy's
Lombardy Region: a large population-based study",Diabetes Research
and Clinical Practice, 93(1), pp. 123-130.
11. Dukes Maurice Nelson Graham (1993), Drug utilization studies:
methods and uses, WHO Regional Office for Europe.
12. Goei Monica (2010), Premixed Insulin for Type 2 Diabetes: A Guide
for Adults, DIANE Publishing, pp. 6,7,8,12.
13. Hank Balzs, Tukarcs va, Kumli Pter, et al. (2005), "Antidiabetic
drug utilization in Hungary", Pharmacy World and Science, 27(3), pp.
263-265.
14. International Diabetes Federation (2012), Global Guideline for Type 2
Diabetes, pp. 55-57.
15. International Diabetes Federation (2012), IDF Diabetes Atlas 5thEdition 2012 Update.
16. International Diabetes Federation (2005), Global Guideline for Type 2
Diabetes, pp. 35-38.
17. Nathan DM, Buse JB, Davidson MB (2009), "European Association for
Study of Diabetes. Medical management of hyperglycemia in type 2
diabetes: a consensus algorithm for the initiation and adjustment oftherapy: a consensus statement of the American Diabetes Association
and the European Association for the Study of Diabetes", Diabetes
Care, 32(1), pp. 193-203.
18. Nissen Steven E, Wolski Kathy (2007), "Effect of rosiglitazone on the
risk of myocardial infarction and death from cardiovascular causes",
New England Journal of Medicine, 356(24), pp. 2457-2471.
7/21/2019 Phn Tch Hot ng Phn Ph i Thuc Ca Cng Ty C Phn Traphaco Giai on 2010 - 2012
53/65
19. Weill Alain, Pata Michel, Tuppin Philippe, et al. (2010), "Benfluorex
and valvular heart disease: a cohort study of a million people with
diabetes mellitus", Pharmacoepidemiology and drug safety, 19(12), pp.
1256-1262.
20. World Health Organization (2003), Introduction to drug utilization
research, World Health Organization, pp. 38-44.
WEBSITES:
21..http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events
/news/2010/01/news_detail_000977.jsp&mid=WC0b01ac058004d5c1.
Truy cp ngy 20/5/2013.
22. http://www.fda.gov/Drugs/DrugSafety/ucm241411.htm.Truy cp ngy
20/5/2013.
23. http://www.who.int/features/factfiles/diabetes/en/index.html. Truy cp
ngy 20/5/2013.
24. http://www.who.int/nmh/countries/vnm_en.pdf. Truy cp ngy20/5/2013.
http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2010/01/news_detail_000977.jsp&mid=WC0b01ac058004d5c1http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2010/01/news_detail_000977.jsp&mid=WC0b01ac058004d5c1http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2010/01/news_detail_000977.jsp&mid=WC0b01ac058004d5c1http://www.fda.gov/Drugs/DrugSafety/ucm241411.htmhttp://www.who.int/features/factfiles/diabetes/en/index.htmlhttp://www.who.int/nmh/countries/vnm_en.pdfhttp://www.who.int/nmh/countries/vnm_en.pdfhttp://www.who.int/features/factfiles/diabetes/en/index.htmlhttp://www.fda.gov/Drugs/DrugSafety/ucm241411.htmhttp://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2010/01/news_detail_000977.jsp&mid=WC0b01ac058004d5c1http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2010/01/news_detail_000977.jsp&mid=WC0b01ac058004d5c1http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2010/01/news_detail_000977.jsp&mid=WC0b01ac058004d5c17/21/2019 Phn Tch Hot ng Phn Ph i Thuc Ca Cng Ty C Phn Traphaco Giai on 2010 - 2012
54/65
PHLC
Phlc 1. Ttrng gi trKNNK cc nhm thuc iu trT (2006-2011)
Phlc 2. Gi trKNNK cc nhm thuc iu trT (2006-2011)
Phlc 3. Slng SK cc nhm thuc iu trT NK(2006-2011)
Phlc 4. Ttrng tng sliu DDD cc nhm thuc T NK(2006-2011)
Phlc 5. Tng slng liu DDD cc thuc iu trT NK(2006- 2011)
Phlc 6. Ttrng gi trKNNK cc thuc iu trT(2006-2011)
Phlc 7.Gi trKNNK ca cc hot cht iu trT (2006-2011)
Phlc 8. Slng SK ca hot cht iu trT NK(2006-2011)
Phlc 9. Ttrng tng sliu DDD ca cc hot cht iu trT NK giai
on (2006-2011)
Ph lc 10. Tng s liu DDD ca cc hot cht iu tr T NK (2006-
2011)
Phlc 11. Ttrng gi trKNNK thuc iu trT ca cc quc gia xut
xgiai on (2006-2011)
Phlc 12. Gi trKNNK thuc iu trT ca cc quc gia xut xgiai
on (2006-2011)
Ph lc 13. S lng SK cc thuc iu trT tcc quc gia xut x
giai on (2006 - 2011)
7/21/2019 Phn Tch Hot ng Phn Ph i Thuc Ca Cng Ty C Phn Traphaco Giai on 2010 - 2012
55/65
Phlc 1. Ttrng gi trKNNK cc nhm thuc iu trT
(2006-2011)
n v: %
Nhm thucNm2006
Nm2007
Nm2008
Nm2009
Nm2010
Nm2011
Biguanid 24,2 17,8 18,3 18,9 22,9 21,2
Sulfonamidv dn xut ure
37,0 46,1 48,4 45,2 40,9 40,7
Thuc T ngung dng kt hp
5,6 6,3 5,3 7,2 8,5 7,5
Cht c ch alphaglucosidase
4,1 3,3 3,3 3,5 3,8 3,9
Thiazolidindion 10,5 4,9 5,9 3,8 4,0 2,0
Cc cht h nghuyt khc tr insulin
2,5 2,5 1,9 1,7 0,2 0,1
Insulin 16,2 19,3 16,9 19,6 19,5 24,7
Tng 100,0 100,0 100,0 100,0 100,0 100,0
Phlc 2. Gi trKNNK cc nhm thuc iu trT (2006-2011)n v: Nghn USD
Tn nhm thucNm2006
Nm2007
Nm2008
Nm2009
Nm2010
Nm2011
Biguanid 3.640 3.270 4.658 5.272 8.127 8.706
Sulfonamidv dn xut ure
5.564 8.488 12.302 12.593 14.496 16.663
Thuc T ng
ung dng kt hp 843 1.151 1.342 2.006 3.023 3.078Cht c chalpha glucosidase
613 603 847 984 1.361 1.584
Thiazolidindion 1.583 898 1.508 1.063 1.433 816
Cc cht h nghuyt khc tr insulin
373 454 486 459 69 30
Insulin 2.432 3.544 4.297 5.462 6.921 10.104
Tng 15.048 18.408 25.441 27.839 35.429 40.981
7/21/2019 Phn Tch Hot ng Phn Ph i Thuc Ca Cng Ty C Phn Traphaco Giai on 2010 - 2012
56/65
Phlc 3. Slng SK cc nhm thuc iu trT nhp khu giai
on 2006-2011
Nhm thuc
S lng SK
Nm2006
Nm2007
Nm2008
Nm2009
Nm2010
Nm2011
Biguanid 29 31 30 38 39 43
Sulfonamidv dn xut ure
47 55 62 59 66 76
Thuc T ngung dngkt hp
6 7 7 15 19 13
Cht c ch alphaglucosidase 2 2 2 2 3 2
Thiazolidindion 22 27 27 17 26 17
Cc cht h nghuyt khc tr insulin
2 2 2 3 2 1
Insulin 18 17 21 21 27 34
Tng 126 141 151 155 182 186
7/21/2019 Phn Tch Hot ng Phn Ph i Thuc Ca Cng Ty C Phn Traphaco Giai on 2010 - 2012
57/65
Phlc 4. Ttrng tng sliu DDD cc nhm thuc T nhp khu
(2006-2011)
n v: %
Nhm thucNm2006
Nm2007
Nm2008
Nm2009
Nm2010
Nm2011
Biguanid 31,67 31,93 11,42 16,01 19,62 16,59
Sulfonamidv dn xut ure
57,07 58,20 76,06 71,83 66,50 72,29
Cht c chalpha glucosidase
0,72 0,52 0,59 0,78 0,98 0,84
Thiazolidindione 3,46 2,95 3,28 2,85 4,09 1,93Cc cht h ng huytkhc tr insulin
1,29 1,15 0,99 0,93 0,06 0,02
Insulin 5,79 5,27 7,66 7,59 8,74 8,33
Tng 100,00 100,00 100,00 100,00 100,00 100,00
Phu lc 5. Tng slng liu DDD cc thuc iu trT nhp khu
(2006-2011)n v: Nghn liu DDD
Nhm thucNm2006
Nm2007
Nm2008
Nm2009
Nm2010
Nm2011
Biguanid 34.555 48.607 21.269 25.935 34.057 38.373
Sulfonamidv dn xut ure
62.273 88.607 141.714 116.338 115.436 167.187
Cht c chalpha glucosidase 784 787 1.106 1.259 1.702 1.941
Thiazolidindion 3.780 4.487 6.105 4.619 7.106 4.469
Cc cht h nghuyt khc trinsulin
1.412 1.743 1.845 1.513 109 45
Insulin 6.321 8.018 14.278 12.290 15.175 19.266
Tng 109.126 152.250 186.317 161.953 173.587 231.281
7/21/2019 Phn Tch Hot ng Phn Ph i Thuc Ca Cng Ty C Phn Traphaco Giai on 2010 - 2012
58/65
7/21/2019 Phn Tch Hot ng Phn Ph i Thuc Ca Cng Ty C Phn Traphaco Giai on 2010 - 2012
59/65
Phlc 7. Gi trKNNK ca cc hot cht iu trT
(2006-2011)
n v: Nghn USD
Tn hot chtNm2006
Nm2007
Nm2008
Nm2009
Nm2010
Nm2011
Acarbose 613 603 847 984 1.361 1.584
Benfluorex 335 416 454 413
Chlorpropamid 96 88 71 87 52 47
Glibenclamid 386 478 566 339 272 574
Glibenclamid,metformin 695 834 1.207 1.545 1.635 2.308
Gliclazid 3.406 6.356 7.867 9.309 10.035 11.083
Gliclazid,metformin
16 15 32 83 304 452
Glimepirid 1.676 1.566 3.798 2.858 4.136 4.958
Insulin 2.432 3.544 4.297 5.462 6.921 10.104
Metformin 3.640 3.271 4.658 5.272 8.127 8.706
Pioglitazon 490 725 928 589 1.352 816Repaglind 38 38 32 47 69 30
Rosiglitazon 1.093 173 580 475 82
Rosiglitazon,metformin
132 302 103 318 600
Glimepirid,metformin
59 179 114
Pioglitazon,
metformin
305 205
Tng 15.048 18.408 25.441 27.839 35.429 40.981
7/21/2019 Phn Tch Hot ng Phn Ph i Thuc Ca Cng Ty C Phn Traphaco Giai on 2010 - 2012
60/65
Phlc 8. Slng SK ca hot cht iu trT nhp khu
(2006-2011)
Tn hot chtS lng SK
Nm2006
Nm2007
Nm2008
Nm2009
Nm2010
Nm2011
Acarbose 2 2 2 2 3 2
Benfluorex 1 1 1 1 0 0
Chlorpropamid 2 2 2 2 1 1
Glibenclamid 12 8 9 6 8 7
Glibenclamid,
metformin 4 3 5 7 6 7Gliclazid 16 24 22 22 24 22
Gliclazid,metformin
1 1 1 3 2 2
Glimepirid 17 21 29 29 33 46
Insulin 18 17 21 21 27 34
Metformin 29 31 30 38 39 43
Pioglitazon 14 19 21 11 22 17
Repaglind 1 1 1 2 2 1Rosiglitazon 8 8 6 6 4 0
Rosiglitazon,metformin
1 3 1 4 6 0
Glimepirid,metformin
1 3 1
Pioglitazon,metformin
2 3
Tng 126 141 151 155 182 186
7/21/2019 Phn Tch Hot ng Phn Ph i Thuc Ca Cng Ty C Phn Traphaco Giai on 2010 - 2012
61/65
Phlc 9. Ttrng tng sliu DDD ca cc hot cht iu trT
nhp khu (2006-2011)
n v: %
Tn hot chtNm2006
Nm2007
Nm2008
Nm2009
Nm2010
Nm2011
Acarbose 0,72 0,52 0,59 0,78 0,98 0,84
Benfluorex 1,25 1,12 0,97 0,89 0,00 0,00
Chlorpropamid 2,88 1,67 3,82 1,87 1,02 0,64
Glibenclamid 11,93 11,07 9,46 5,35 3,96 7,82
Gliclazid 29,05 37,42 40,54 45,59 40,02 34,44Glimepirid 13,20 8,04 22,25 19,02 21,51 29,38
Insulin 5,79 5,27 7,66 7,59 8,74 8,33
Metformin 31,67 31,93 11,42 16,01 19,62 16,59
Pioglitazon 2,37 2,45 2,60 1,67 3,74 1,93
Repaglind 0,04 0,03 0,02 0,05 0,06 0,02
Rosiglitazon 1,10 0,50 0,67 1,18 0,35 0,00
Tng 100,00 100,00 100,00 100,00 100,00 100,00
7/21/2019 Phn Tch Hot ng Phn Ph i Thuc Ca Cng Ty C Phn Traphaco Giai on 2010 - 2012
62/65
Phlc 10. Tng sliu DDD ca cc hot cht iu trT nhp khu
giai on 2006-2011
n v: nghn liu DDD
Tn hot chtNm2006
Nm2007
Nm2008
Nm2009
Nm2010
Nm2011
Acarbose 784 787 1.106 1.259 1.702 1.941
Benfluorex 1.367 1.698 1.800 1.440 0 0
Chlorpropamid 3.146 2.540 7.117 3.031 1.767 1.489
Glibenclamid 13.016 16.859 17.624 8.670 6.868 18.094
Gliclazid 31.703 56.973 75.525 73.840 69.461 79.648
Glimepirid 14.408 12.235 41.448 30.797 37.341 67.957
Insulin 6.321 8.018 14.278 12.290 15.175 19.266
Metformin 34.555 48.607 21.269 25.935 34.057 38.373
Pioglitazon 2.581 3.723 4.850 2.709 6.500 4.469
Repaglind 45 45 45 73 110 45
Rosiglitazon 1.199 764 1.254 1.910 606 0
Tng 109.126 152.249 186.317 161.953 173.587 231.281
7/21/2019 Phn Tch Hot ng Phn Ph i Thuc Ca Cng Ty C Phn Traphaco Giai on 2010 - 2012
63/65
Phlc 11. Ttrng gi trKNNK thuc iu trT ca cc quc gia
xut x(2006-2011)
n v: %
Tn qucgia
Nm2006
Nm2007
Nm2008
Nm2009
Nm2010
Nm2011
Argentina 0,1 0,0 0,1 0,1 0,1 0,0
Bangladesh 0,0 0,0 0,0 0,3 0,4 0,3
Canada 1,6 1,7 1,1 0,4 0,7 0,4
Trung Quc 0,0 0,0 1,0 0,0 0,0 0,1
Cyprus 0,7 2,0 1,0 0,5 0,7 0,3an Mch 10,4 14,2 8,5 12,2 10,0 16,3
Php 48,2 47,8 44,0 48,1 43,1 42,1
c 7,8 6,5 6,6 7,0 6,5 9,0
n 7,3 9,7 8,2 7,4 12,2 13,4
Indonesia 0,8 0,4 1,1 1,1 0,4 0,3
8,5 6,5 11,7 6,0 7,1 7,6
Hn Quc 1,7 2,3 2,4 3,2 3,5 3,9
Malaysia 0,4 0,5 0,3 0,5 0,0 0,2
Pakistan 1,6 0,4 1,2 1,1 2,5 0,9
Ba Lan 3,4 4,5 7,1 6,6 4,9 2,7
Singapo 0,0 0,0 0,0 0,1 0,1 0,0
Ty BanNha
1,6 1,7 3,3 1,9 1,4 0,0
a Loan 0,0 0,7 1,5 1,3 1,1 0,9
Th nh k 0,0 0,2 0,1 0,6 0,4 0,5Anh 0,0 0,0 0,0 0,5 0,1 0,0
M 6,0 1,0 0,8 1,3 1,1 0,8
Israel 0,0 0,0 0,0 0,0 3,7 0,0
c 0,0 0,0 0,0 0,0 0,0 0,4
Tng 100,0 100,0 100,0 100,0 100,0 100,0
7/21/2019 Phn Tch Hot ng Phn Ph i Thuc Ca Cng Ty C Phn Traphaco Giai on 2010 - 2012
64/65
Phlc 12. Gi trKNNK thuc iu trT ca cc quc gia xut x
(2006-2011)
n v: Nghn USD
Tn qucgia
Nm2006
Nm2007
Nm2008
Nm2009
Nm2010
Nm2011
Argentina 8 9 18 20 30 20
Bangladesh 71 136 129
Canada 235 314 287 100 254 161
Trung Quc 260 34
Cyprus 107 370 263 141 257 125an Mch 1.560 2.613 2.150 3.386 3.554 6.690
Php 7.254 8.790 11.188 13.388 15.285 17.273
c 1.175 1.202 1.674 1.954 2.318 3.677
n 1.093 1.779 2.090 2.061 4.320 5.477
Indonesia 120 67 284 299 139 112
1.279 1.192 2.974 1.661 2.515 3.124
Hn Quc 259 426 607 898 1.227 1.591
Malaysia 63 95 81 140 10 63Pakistan 235 81 309 295 896 352
Ba Lan 515 827 1.800 1.825 1.733 1.089
Singapo 35 22 11
Ty BanNha
248 306 827 535 484
a Loan 126 372 364 395 357
Th nh k 36 33 168 138 198
Anh 10 139 23M 896 176 214 360 397 320
Israel 1.294
c 179
Tng 15.048 18.408 25.441 27.839 35.429 40.981
7/21/2019 Phn Tch Hot ng Phn Ph i Thuc Ca Cng Ty C Phn Traphaco Giai on 2010 - 2012
65/65
Phlc 13. Slng SK cc thuc iu trT tcc quc gia xut x
Tn qucgia
S lng SK
Nm2006
Nm2007
Nm2008
Nm2009
Nm2010
Nm2011
Argentina 1 1 2 1 1 1
Bangladesh 4 7 5
Canada 6 6 6 3 3 3
Trung Quc 1
Cyprus 3 3 4 3 2 5
an Mch 9 8 8 8 10 9
Php 14 12 9 10 13 10c 12 11 12 11 11 13
n 41 56 53 55 77 78
Indonesia 4 2 6 5 7 4
3 4 3 3 3 2
Hn Quc 10 13 16 17 16 20
Malaysia 4 4 2 3 1 2
Pakistan 7 4 7 3 9 13
Ba Lan 5 8 10 10 5 9
Singapo 1 1 1
Ty BanNha
3 3 4 2 2
a Loan 2 3 4 4 3
Th nh k 1 1 1 1 1
Anh 2 5 4
M 4 3 3 6 4
Israel 1 4
c 2
Tng 126 141 151 155 182 186